FDA Adverse Event Injury Summary report: N

AZUR SOFT3D DETACHABLE 10

MDR report key: 19231578 · Received May 2, 2024

Report

Report Number
2032493-2024-00351
Event Type
Injury
Date Received
May 2, 2024
Date of Event
April 18, 2024
Report Date
May 2, 2024
Manufacturer
MICROVENTION, INC
Product Code
HCG
UDI-DI
04987892128400
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AT THE TIME THIS COMPLAINT WAS RECEIVED, THIS PRODUCT WAS AN EXPORTED DEVICE THAT WAS NOT CLEARED OR APPROVED FOR MARKETING IN THE U.S. THE COMPLAINT IS BEING REPORTED BASED ON THIS PRODUCT MEETING SIMILAR PRODUCT CRITERIA. THIS DEVICE IS SIMILAR TO V-TRAK HYDRO SOFT 3D, 510K # K161367. INVESTIGATION FINDINGS. ITEMS RETURNED: - N/A. VISUAL ANALYSIS: A VISUAL INSPECTION OF THE DEVICE CAPTURED IN THIS FILE COULD NOT BE PERFORMED AS A PHYSICAL DEVICE WAS NOT RETURNED FOR EVALUATION, NOR WERE ANY IMAGES OF THE DEVICE PROVIDED IN PLACE OF A DEVICE RETURN. PROCEDURE AND MEDICAL IMAGING WAS NOT PROVIDED FOR THIS INVESTIGATION. INVESTIGATION FINDINGS: WITHOUT THE RETURN AND PHYSICAL EVALUATION OF THE DEVICE, THE INVESTIGATION CANNOT DEFINITIVELY DETERMINE IF A CONDITION EXISTED THAT WOULD HAVE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. WITHOUT IMAGING, THE INVESTIGATION CANNOT VERIFY THE EVENT OCCURRED AS DESCRIBED, NOR COULD THE INVESTIGATION DEFINITIVELY DETERMINE THE CAUSE OF THE REPORTED EVENT. BASED ON A REVIEW OF THE DEVICE¿S RISK DOCUMENTATION, THE REPORTED EVENT DID NOT INDICATE THERE WERE ANY POTENTIAL OR NEW MANUFACTURING, DESIGN, QUALITY, OR OTHER SYSTEMIC ISSUES, OR NON-CONFORMANCES. THE COMPLAINT CODE IS MONITORED THROUGH THE TRENDING PROCESS; CORRECTIVE ACTION IS DETERMINED, AS NEEDED, THROUGH THIS PROCESS. INVESTIGATIONS OF HISTORIC COMPLAINT FILES WITH SIMILAR COMPLAINT CATEGORY CODING ARE RECORDED IN THE COMPLAINT HANDLING SYSTEM; WITHOUT THE ABILITY TO PERFORM AND ANALYSIS OF THE DEVICE, THIS INVESTIGATION CANNOT IDENTIFY WITH CERTAINTY ANY POTENTIAL ROOT CAUSES. BATCH REVIEW: A SEARCH FOR NON-CONFORMANCES ASSOCIATED WITH THIS PART/LOT NUMBER COMBINATION DID NOT REVEAL ANY PRODUCTION-RELATED ISSUES RELEVANT TO THE COMPLAINT THAT OCCURRED DURING MANUFACTURING OF THE DEVICE. COMPLAINT SYSTEM REVIEW: THERE ARE NO SIMILAR COMPLAINTS BASED ON THE COMPLAINT CATEGORY REGARDING THIS BATCH NUMBER FROM THE LAST TWO YEARS RECORDED IN THE COMPLAINT SYSTEM AT THE TIME OF THIS INVESTIGATION. IFU REVIEW (ADDITIONAL INFORMATION CAN BE FOUND IN THE IFU): PLEASE REFER TO THE JAPANESE IFU FOR PRECAUTIONS, WARNINGS, AND FURTHER INFORMATION. THE FOLLOWING IS TAKEN FROM THE ENGLISH VERSION: 5.INTRODUCTION AND DEPLOYMENT OF THE COIL DELIVERY SYSTEM 5-3 SEAT THE DISTAL TIP OF THE INTRODUCER SHEATH AT THE DISTAL END OF THE MICROCATHETER HUB AND CLOSE THE RHV LIGHTLY AROUND THE INTRODUCER SHEATH TO SECURE THE RHV TO THE INTRODUCER SHEATH. CAUTION·DO NOT OVER-TIGHTEN THE RHV AROUND THE INTRODUCER SHEATH. [EXCESSIVE TIGHTENING COULD DAMAGE THE PUSHER CATHETER SUCH AS KINKING.]. 5-4 PUSH THE COIL INTO THE LUMEN OF THE MICROCATHETER. CAUTION·AVOID CATCHING THE COIL ON THE JUNCTION BETWEEN THE INTRODUCER SHEATH AND THE HUB OF THE MICROCATHETER. ·INITIATE TIMING USING A STOPWATCH OR TIMER AT THE MOMENT THE COIL ENTERS THE MICROCATHETER. 5-5 PUSH THE PUSHER CATHETER THROUGH THE MICROCATHETER UNTIL THE PROXIMAL END OF THE PUSHER CATHETER MEETS THE PROXIMAL END OF THE INTRODUCER SHEATH. LOOSEN THE RHV. RETRACT THE INTRODUCER SHEATH JUST OUT OF THE RHV. CLOSE THE RHV AROUND THE PUSHER CATHETER. CAUTION·AVOID KINKING THE PUSHER CATHETER AND INTRODUCER SHEATH. ·TO PREVENT PREMATURE HYDRATION OF THE AZUR SYSTEM, ENSURE THAT THERE IS FLOW FROM THE SALINE FLUSH 5-7 UNDER FLUOROSCOPIC GUIDANCE, SLOWLY ADVANCE THE COIL INTO THE VESSEL/ANEURYSM FROM THE TIP OF THE MICROCATHETER. 5-8 CONTINUE TO ADVANCE THE COIL INTO THE LESION UNTIL OPTIMAL DEPLOYMENT IS ACHIEVED. REPOSITION IF NECESSARY. CAUTION·IF THE COIL SIZE IS NOT SUITABLE, REMOVE AND REPLACE WITH ANOTHER MORE APPROPRIATELY SIZED COIL. ·DO NOT ROTATE THE PUSHER CATHETER DURING OR AFTER DEPLOYMENT OF THE COIL INTO THE VESSEL/ANEURYSM. [ROTATING THE PUSHER CATHETER MAY RESULT IN A STRETCHED COIL OR PREMATURE DETACHMENT OF THE COIL FROM THE PUSHER CATHETER, WHICH COULD RESULT IN COIL MIGRATION.]. INVESTIGATION CONCLUSION. THE PHYSICAL DEVICE WAS NOT AVAILABLE FOR EVALUATION TO DETERMINE IF A CONDITION EXISTED THAT WOULD HAVE CAUSED OR CONTRIBUTED TO EVENT. SUPPLEMENTAL IMAGING WAS ALSO UNAVAILABLE FOR REVIEW; WITHOUT IMAGING, THE INVESTIGATION CANNOT VERIFY THE EVENT OCCURRED AS DESCRIBED, NOR COULD THE INVESTIGATION DEFINITIVELY DETERMINE THE CAUSE OF THE REPORTED EVENT. THIS INFORMATION MAY BE UPDATED IF ADDITIONAL INFORMATION IS PROVIDED AT A LATER DATE. H3 OTHER TEXT : DEVICE DISCARDED.

Description of Event or Problem · 0

IT WAS REPORTED THE COIL WAS ATTEMPTED TO BE USED FOR TREATMENT OF PAVM. A COMPETITOR¿S COIL AND ANCHOR AND AN AZUR SOFT3D (6-19) WERE IMPLANTED SUCCESSFULLY PRIOR TO THE COIL CONCERNED. DURING THE POSITIONING OF THE COIL CONCERNED, THE IMPLANT BECAME STRETCHED. THE COIL SYSTEM WAS ATTEMPTED TO BE REMOVED FROM THE PATIENT, HOWEVER, THE IMPLANT DETACHED UNINTENTIONALLY AND WAS IN THE PULMONARY ARTERY. THE AZUR SOFT3D IMPLANT WAS REMOVED WITH A SNARE AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH NO HEALTH DAMAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
840850 AZUR SOFT3D DETACHABLE 10 DEVICE, NEUROVASCULAR EMBOLIZATION HCG MICROVENTION, INC MV-HS00510 0000442857 04987892128400

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention